UCL scientists
co-sign a letter to the Telegraph expressing concerns over the proposed Pfizer
takeover of AstraZeneca. Professor John Hardy (UCL Institute of Neurology) says
"takeover bids like this are a sign of weakness in the pharma sector."
Read: Telegraph
Close
